Gastroenterology
Volume 126, Issue 2 , Pages 469-475 , February 2004

Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: Results of a randomized study

  • Christophe Bureau

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Christophe Bureau, M.D., Service d’Hépato-Gastro-Entérologie, Fédération Digestive CHU Purpan, Place du Dr Baylac, 31059, Toulouse CEDEX, France; fax: (33) 5-61-77-90-15
    • Service d’Hépato-Gastro-Entérologie, Fédération Digestive, Centre Hospitalier Universitaire Purpan et U531 Institut National de la Santé et de la Recherche Médicale, Toulouse, France
    • ,
  • Juan carlos Garcia-Pagan

      Affiliations

    • Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives; Hospital Clinic, Institut D’Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    • ,
  • Philippe Otal

      Affiliations

    • Service de Radiologie, Centre Hospitalier Universitaire Rangueil, Toulouse, France
    • ,
  • Gilles Pomier-Layrargues

      Affiliations

    • Liver Unit, Hôpital Saint-Luc, Centre Hospitalier de l’Université de Montreal and Université de Montreal, Montreal, Quebec, Canada
    • ,
  • Valérie Chabbert

      Affiliations

    • Service de Radiologie, Centre Hospitalier Universitaire Rangueil, Toulouse, France
    • ,
  • Carlos Cortez

      Affiliations

    • Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives; Hospital Clinic, Institut D’Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    • ,
  • Pierre Perreault

      Affiliations

    • Liver Unit, Hôpital Saint-Luc, Centre Hospitalier de l’Université de Montreal and Université de Montreal, Montreal, Quebec, Canada
    • ,
  • Jean marie Péron

      Affiliations

    • Service d’Hépato-Gastro-Entérologie, Fédération Digestive, Centre Hospitalier Universitaire Purpan et U531 Institut National de la Santé et de la Recherche Médicale, Toulouse, France
    • ,
  • Juan G. Abraldes

      Affiliations

    • Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives; Hospital Clinic, Institut D’Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    • ,
  • Louis Bouchard

      Affiliations

    • Liver Unit, Hôpital Saint-Luc, Centre Hospitalier de l’Université de Montreal and Université de Montreal, Montreal, Quebec, Canada
    • ,
  • José Ignacio Bilbao

      Affiliations

    • Department of Radiology, Clinica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona, Spain
    • ,
  • Jaume Bosch

      Affiliations

    • Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives; Hospital Clinic, Institut D’Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    • ,
  • Hervé Rousseau

      Affiliations

    • Service de Radiologie, Centre Hospitalier Universitaire Rangueil, Toulouse, France
    • ,
  • Jean pierre Vinel

      Affiliations

    • Service d’Hépato-Gastro-Entérologie, Fédération Digestive, Centre Hospitalier Universitaire Purpan et U531 Institut National de la Santé et de la Recherche Médicale, Toulouse, France

Received 16 June 2003 ,Accepted 30 October 2003.

References 

  1. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy (randomized trials for secondary prophylaxis of variceal bleeding—an updated meta-analysis). Scand J Gastroenterol. 2002;37:249–252
  2. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts (comparison with paracentesis in patients with cirrhosis and refractory ascites—a randomized trial. French Group of Clinicians and a Group of Biologists). J Hepatol. 1996;25:135–144
  3. Rossle M, Ochs A, Gulberg V. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707
  4. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–1847
  5. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, DeMeo J, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112:889–898
  6. Casado M, Bosch J, Garcia-Pagan JC, Banares R, Bandi JC, Escorsell A, et al. Clinical events after transjugular intrahepatic portosystemic shunt (correlation with hemodynamic findings). Gastroenterology. 1998;114:1296–1303
  7. Nishimine K, Saxon RR, Kichikawa K, Mendel-Hartvig J, Timmermans HA, Shim HJ, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts (experimental results in swine). Radiology. 1995;196:341–347
  8. Haskal ZJ, Davis A, McAllister A, Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts (experimental evaluation). Radiology. 1997;205:682–688
  9. DiSalle RS, Dolmatch BL. Treatment of TIPS stenosis with ePTFE graft-covered stents. Cardiovasc Intervent Radiol. 1998;21:172–175
  10. Haskal ZJ. Improved patency of transjugular intrahepatic portosystemic in humans (creation and revision with PTFE stent-grafts). Radiology. 1999;213:759–766
  11. Andrews RT, Saxon RR, Bloch RD, Petersen BD, Uchida BT, Rabkin JM, et al. Stent-grafts for de novo TIPS (technique and early results). J Vasc Interv Radiol. 1999;10:1371–1378
  12. Cejna M, Peck-Radosavljevic M, Thurnher SA, Hittmair K, Schoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts (initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis). Radiology. 2001;221:437–446
  13. Otal P, Smayra T, Bureau C, Peron JM, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol. 2002;178:141–147
  14. Burroughs AK, Bosch J, Garcia-Tsao , Henderson JM, Laine L, Nevens F, et al. Definitions of key events (let’s try again). In:  de Franchis R editors. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Portal hypertension III. Oxford: Blackwell Science; 2000;p. 13–21
  15. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164–176
  16. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1993;4:779–786
  17. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology. 1997;25:1064–1069
  18. Sanyal AJ, Mirshahi F. Endothelial cells lining transjugular intrahepatic portosystemic shunts originate in hepatic sinusoids (implications for pseudointimal hyperplasia). Hepatology. 1999;29:710–718
  19. Otal P, Rousseau H, Vinel JP, Ducoin H, Hassissene S, Joffre F. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent. J Vasc Interv Radiol. 1999;10:183–188
  20. Bloch R, Pavcnik D, Uchida BT, Krajina A, Kamino T, Timmermans H, et al. Polyurethane-coated Dacron-covered stent-grafts for TIPS (results in swine). Cardiovasc Intervent Radiol. 1998;21:497–500
  21. Bolognesi M, Balducci G, Garcia-Tsao G, Gatta A, Gines P, Merli M, et al. Complications in the medical treatment of portal hypertension. In:  de Franchis R editors. Portal hypertension III (Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies). Oxford: Blackwell Science; 2000;p. 180–203
  22. Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297–1300
  23. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401–1407
  24. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–1059
  25. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930–934
  26. Bureau C, Otal P, Chabbert V, Péron JM, Rousseau H, Vinel JP. Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology. 2002;36:1554
  27. Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology. 2000;31:358–363
  28. Meddi P, Merli M, Lionetti R, De Santis A, Valeriano V, Masini A, et al. Cost analysis for the prevention of variceal rebleeding (a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients). Hepatology. 1999;29:1074–1077

☆ Supported by a grant from Programme Hospitalier de Recherche Clinique (97/63N) and from the Instituto de Salud Carlos III (CO3/02).

PII: S0016-5085(03)01797-9

doi: 10.1053/j.gastro.2003.11.016

Gastroenterology
Volume 126, Issue 2 , Pages 469-475 , February 2004

Article Tools

* Image Usage & Resolution